Home
>
National Drug Code (NDC)
>
Flecainide Acetate
Flecainide Acetate - 0054-0012-21 - (flecainide acetate)
Drug Information of Flecainide Acetate
| Product NDC: | 0054-0012 |
| Proprietary Name: | Flecainide Acetate |
| Non Proprietary Name: | flecainide acetate |
| Active Ingredient(s): | 150 mg/1 & nbsp; flecainide acetate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Flecainide Acetate
| Product NDC: | 0054-0012 |
| Labeler Name: | Roxane Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076278 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20030114 |
Package Information of Flecainide Acetate
| Package NDC: | 0054-0012-21 |
| Package Description: | 60 TABLET in 1 BOTTLE (0054-0012-21) |
NDC Information of Flecainide Acetate
| NDC Code | 0054-0012-21 |
| Proprietary Name | Flecainide Acetate |
| Package Description | 60 TABLET in 1 BOTTLE (0054-0012-21) |
| Product NDC | 0054-0012 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | flecainide acetate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20030114 |
| Marketing Category Name | ANDA |
| Labeler Name | Roxane Laboratories, Inc. |
| Substance Name | FLECAINIDE ACETATE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antiarrhythmic [EPC] |
